As part of Purdue Pharma’s settlement, a new company will provide numerous doses of opioid overdose reversal and addiction treatments. Credit: Bob Williams from Pixabay.

The US Department of Justice is seeking approximately $13bn in criminal and civil penalties from Purdue Pharma over opioid claims filed against the company.

Last August, the company offered to settle the more than 2,000 lawsuits filed over its contribution to the opioid crisis for between $10bn and $12bn.

Go deeper with GlobalData

  • ReportsLogo

  • ReportsLogo

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

Later, in September, Purdue filed for Chapter 11 bankruptcy to settle the lawsuits. The agreement was valued at more than $10bn for resolving the litigation with 24 states, five US territories and lead lawyers for more than 2,000 cities and counties, along with other claimants.

As part of the bankruptcy reorganisation plan, the government prosecutors demand that the company pay around $6.2bn in criminal penalties and almost $5b in civil compensation, reported Bloomberg citing people familiar with the matter.

The compensation is for the money spent to fight the opioid epidemic, claimed to involve illegal marketing of Purdue’s OxyContin opioid painkiller, in the US.

Additional creditors are also seeking compensation as part of the company’s Chapter 11 case, including people who lost a loved one to opioid addiction, hospitals that treated addicts and state and local governments.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

If the court rules against Purdue for criminal violations related to the illegal OxyContin marketing allegations, the company could be required to pay an additional $3bn.

Neither Purdue nor the Sackler family, which runs the company, have currently been charged with criminal wrongdoing or civil violations in the investigations.

In 2007, the company settled a federal criminal prosecution, when it pleaded guilty to ‘misbranding’ OxyContin. The company and three of its top executives agreed to pay more than $630m in criminal and civil penalties at the time.